THE EFFECTOR cell(s) in anti-tumour immune responses
has not yet been clearly identified. A previous study using Moloney sarcoma virus (MSV) induced tumours indicated that non-T cells were responsible for anti-tumour responses (Lamon et al., 1972) . However, two other reports demonstrated that T cells were the critical effector cells (Leclerc et al., 1973; Gorczynski, 1974 ) while yet another study implicated macrophages as effector cells in a nonspecific killing mechanism in the same tumour system (Owen and Seeger, 1973) . It has been suggested that these discrepancies might be due to the use of different assays for anti-tumour immunity. The studies by Lamon et al. (1972) used the in vitro microcytotoxicity assay while Leclerc et al. (1973) used an in vitro chromium release technique and Gorczynski (1974) employed an in vivo adoptive transfer method. Owen and Seeger (1973) applied their isotopic technique (1251-UdR) which measures inhibition of tumour growth, thus approximating the classic colony inhibition method of Hellstrom and Hellstrom (1970) .
Since the MSV system is quite unique, in that tumours commnonly regress after a certain size is attained, it is possible that more than one mechanism may be involved in anti-tumour immunity in this case. The purpose of the present study was to examine the nature of the effector cell(s) in a chemically induced tumour system in which tumours never regress spontaneously. Also, both an in vitro (colony inhibition) and an in vivo (adoptive transfer) assay were used to measure anti-tumour responses.
MATERIALS AND METHODS
Mice.-DBA/2J female mice (Jackson Laboratories, Bar Harbor, Maine) aged 2-4 months were used exclusively in these studies.
Tumour system-.A methylcholanthrene induced rhabdomyosarcoma (Jackson Laboratories) was used herein. The growth characteristics of this tumour and the methods used for passaging it both in vitro and in vivo have been described in detail previously (Whitney, Levy and Smith, 1974) . The tumour was initiated in DBA/2J mice and has been maintained in this strain for more than 2 years in our laboratory. It can be transplanted to 1DBA/2J mice with low doses of tumour cells (< 104), but it does not grow in other strains tested (CBA/J and AKR) even at a dose of 106 cells. This tumour is strongly immunogenic in its strain of origin since animals immunized by surgical resection of growing transplanted tumours uniformly rejected a challenge inoculum of 105 tumour cells, which is 10 times the dose that produces tumours in 100% of untreated mice. Resected mice were the immune animals used in these experiments. The specificity of the immune spleen cells for the immunizing tumour cells was established by the observation that these cells prevented the grow'th of the tumour under study but not a mammary adenocarcinoma or an unrelated methylcholanthrene induced tumour (both of DBA/2J origin) in the adoptive transfer test.
Preparationt of antisera. Rabbit antimouse brain associated 0 serum (anti-BAO) was prepared as described by Barker, Rheins and St Pierre (1973) . The serum was adsorbed with mouse liver homogenates (6 ml anti-serum/1-5 ml packed liver tissue) for 30 min at room temperature, inactivated at 56°C for 30 min and sterilized by Millipore filtration.
Treatment of appropriately immune cells with this anti-BAO and complement did not decrease the number of plaque-forming cells to 2,4-dinitrophenyl coated sheep erythrocytes. Also, there was no detectable killing of spleen cells from congenitally athymic nude mice. Further, the proportion of spleen cells binding labelled anti-Ig increased after anti-BAO treatment. Finally, the percentage of spleen cells killed by anti-BAO (see Table I ) was considerably Sheep anti-mouse immunoglobulin serum (anti-Ig) was prepared by injecting purified mouse Ig in complete Freund's adjuvant into sheep. Sheep were immunized by 2 intramuscular injections of 10 mg of mouse Ig in a 1 0 ml volume of 5000 complete Freund's adjuvant (Difco) 2 weeks apart. The antiserum was adsorbed -with DBA/2J thymus cells (10 ml antiserum/108 cells) for 30 min at room temperature, inactivated and filter sterilized. Antiserum used for autoradiography was fractionated by repeated precipitation with 3300 saturated (NH 4)2804, after which it was dialysed exhaustively against physiological saline.
Cytotoxic testing of antisera. Thymus or spleen cells were first treated with NH 4C1 (083% w/v) to remove erythrocytes. 107 cells were then incubated with 01 ml anti-BAO or anti-Ig (1: 2 final dilution) plus 0 05 ml guinea-pig serum as the complement (C') source and 0 05 ml phosphate buffered saline (PBS) for 60 min at 37°C. At the end of the incubation period, they were washed once with PBS, diluted with trypan blue and the dead cells enumerated.
In order to prepare cells for anti-tumour immunity testing, 6 x 107 cells were incubated with 0 4 ml anti-BAO or anti-Ig plus 041 ml C' and 0 3 ml PBS for 60 min at 37°C. They w"ere then -washed twice with PBS before counting.
Autoradiography.-The percentage of Ig bearing spleen lymphocytes was determined using a direct autoradiographic procedure. Fractionated sheep anti-mouse Ig was iodinated by the chloramine-T procedure (Hunter and Greenwood, 1962) . The exact method for preparation and development of slides has been described elsewhere (Kelly et al., 1974) . The specific activity of the '251-anti- also reduced by passage through a nylon wool column as has been described previously (Julius, Simpson and Herzenberg, 1973) . Morphological examination of the effluent population indicated no macrophages were present, but the possibility that macrophage precursors were still present cannot be excluded.
Mitogen stim ulation. Whole spleen cells and separated fractions wvere cultured in microtitre plates and were stimulated by concanavalin A (con A) and E. coli endotoxin (lipopolysaccharide, LPS) at 1 and 25 tg/ml respectively. The complete method has been described in detail previously (Whitney et al., 1974) .
Tests for anti-tuntour inoniunity. The colony inhibition technique of Hellstrom and Hellstrom (1970) w%vas used as described previously (XVhitney et al., 1974) to assess anti-tumour immunity in vitro.
An adoptive transfer technique termed neutralization, originally described by Winn (1959) was used to measure anti-tumour immunity in vivo. 104 tumour cells were mixed with 3 x 106 spleen cells (whole or fractionated) and were injected subcutaneously into normal recipients after a 1 h incubation together in vitro at 37TC. Mice were then observed for the development of tumours as previously described (Whitney et al., 1974) .
Statistics. Neutralization data were analysed using the Fisher Exact Test for non-parametric statistics. All other results are expressed as mean values + s.e. mean. The statistical significance of differences in mean values was determined by Student's t test. Differences w%ere considered to be significant if the probability that the observed difference occurred by chance alone was less than 50o (i.e., P < 0.05).
RESULTS
Several methods were used to demonstrate the specificity of the antisera for either T or B cells and the ability of the nylon wool to reduce the proportion of B cells. Cytotoxicity tests showed that anti-BAO serum killed 98 10% and 27 ± 1% of thymus and spleen cells respectively while anti-Ig serum had no effect on thymus cells and killed 47 ± 100 of spleen cells (Table I) In the series of neutralization experiments performed to assess the effects of anti-BAO and anti-Ig serum and nylon wool on anti-tumour immunity, untreated immune spleen cells prevented tumour development in all 27 mice tested ( Table  V) . Treatment of the immune cells with anti-Ig serum, or by passage through nylon wool, did not reduce the degree of protection since none of the mice receiving these cell populations developed tumours. In contrast, anti-BAO treatment virtually abolished the protective effect as 24/25 
DISCUSSION
The present data clearly demonstrated that anti-BAO serum abolished the antitumour effects of spleen cells from tumour immunized mice as assayed in vitro by the colony inhibition method and in vivo by an adoptive transfer technique. In contrast, anti-Ig serum had no effect on anti-tumour responises in vitro or in vivo. Passage of immune spleen cells through a nylon wool column, which eliminated macrophages and reduced the percentage of Ig bearing cells to about 400, also did not alter their anti-tumour effects in vivo. It can be concluded from these observations that T and not B lymphocytes are the anti-tumour effector cells in this chemically induced rhabdomyosarcoma tumour system. Thus, this syngeneic tumour system seems to have the same rejection mechanism with regard to the type of effector cell as does the classic allograft reaction to H-2 antigens (Cerottini, Nordin and Brunner, 1970) and the tumour allograft reaction (Freedman, Cerottini and Brunner, 1972) .
It has recently been reported that T lymphocytes could adoptively transfer immunity to plasma cell tumours of mice (Rouse, Rollinghoff and Warner, 1973) . Therefore, it has now been shown that anti-tumour immunity can be transferred in vivo only by T cells in chemically and virally (Gorczynski, 1974) induced " solid" tumour systems as well as in a lymphoid tumour system which was, however, grown in solid form. The in vivo relevance of other mechanisms of anti-tumour responses involving B cells (Lamon et al., 1972) which have been observed in vitro remains to be shown. The present observations certainly do not exclude the possibility that macrophages may also be important in the effector mechanism. For example, T lymphocytes adoptively transferred might well recruit recipient macrophages to effect cell killing. Indeed, a recent report by Zarling and Tevethia (1973) showed that tumour cell neutralization by immune spleen cells was much less efficient if recipients were pre-treated with silica, a specific macrophage toxin. Chia and Festenstein (1973) Lamon et al. (1973) using the MSV tumour system has shown that T cells can have anti-tumour effects in the microcytotoxicity assay, depending on the point in tumour growth when they are tested. They were found to be active just before tumour development and just after regression whereas the non-T population was also active at these times but retained its activity for extended periods after regression. These findings suggest that the major effector mechanism may change during tumour growth and that it may be different from that of completely immunized, tumourfree mice. However, Gorezynski (1974) demonstrated the in vivo T cell requirement with cells taken from mice at a time (28 days after MSV injection) when T cell activity had waned according to Lamon et al. (1973) .
Because model tumour systems may vary extensively in their interaction with the immune system, and because it is possible that the different methods of assay may in fact measure the activity of a variety of cell populations, it is impossible to draw wide ranging conclusions from limited experimental evidence. It is clear that additional studies to test effector cell function and identity over the complete range of tumour growth, and with a variety of tumour systems, should be undertaken. It is also clear that a variety of assays for tumour immunity should be used simultaneously so that reliable conclusions can be drawn regarding the significance of observed results.
